The Federal Trade Commission has approved an application by Supervalu Inc. to sell a Shop ’n Save supermarket in Berryville, Va., and another in Martinsburg, W.Va. to Ahold/Delhaize. Supervalu acquired the stores under the FTC’s Oct. 31, 2016 modified final order settling charges that the $28 billion merger of supermarket chain operators Koninklijke Ahold and […]
Category Archives: Federal Trade Commission
FTC Approves Final Order Imposing Conditions on Joint Venture among Three Producers of PET Resin
Following a public comment period, the Federal Trade Commission has approved a final order settling charges that three PET resin producers’ proposed $1.1 billion joint acquisition out of bankruptcy of an under-construction PET production facility would violate federal antitrust law. According to the complaint, which was first announced in December 2018, without a remedy, the […]
FTC Returns $1.95 Million to Consumers Who Bought NutriMost Ultimate Fat Loss System in the Pittsburgh Area
The Federal Trade Commission is mailing 3,483 checks totaling more than $1.95 million to consumers who bought the NutriMost Ultimate Fat Loss System between October 1, 2012 and August 9, 2016, in the Pittsburgh, Pennsylvania area. Each consumer will receive a refund of $560.54. According to the FTC’s April 2017 complaint, NutriMost, LLC, NutriMost Doctors, […]
FTC Approves Final Order with SoFi
Following a public comment period, the Federal Trade Commission has approved a final consent order with SoFi, resolving allegations that it misrepresented how much money student loan borrowers have saved or will save from refinancing their loans with the company. In its October 2018 complaint, the FTC alleged that SoFi made prominent false statements about […]
FTC Approves Final Order Imposing Conditions on Penn National Gaming, Inc.’s Acquisition of Pinnacle Entertainment, Inc.
Following a public comment period, the Federal Trade Commission has approved a final order settling charges that casino operator Penn National Gaming, Inc.’s $2.8 billion agreement to acquire Pinnacle Entertainment, Inc. likely would be anticompetitive. According to the complaint, which was first announced in October 2018, the proposed acquisition would harm competition for casino services—namely, slots […]
FTC Approves Application from Praxair and Linde for Sale of an Industrial Gases Plant to LyondellBasell Acetyls, LLC
The Federal Trade Commission has approved an application from industrial gas suppliers Praxair and Linde to divest a hydrogen gas and carbon monoxide gas plant to LyondellBasell Acetyls, LLC. The divestiture of the plant is required under the FTC’s October 22, 2018 proposed order, which requires Praxair and Linde to divest certain industrial gases assets […]
FTC Announces Agenda for the Tenth Session of its Hearings on Competition and Consumer Protection in the 21st Century
The Federal Trade Commission today announced the agenda for the tenth session of its Hearings Initiative. The session, focused on competition and consumer protection issues in broadband markets, will take place on March 20, 2019 at the Constitution Center Auditorium at 400 7th St., SW, Washington D.C. The hearing originally was scheduled for January 16, […]
FTC Approves Final Consent Order against Company and Owner Who Allegedly Made Unsupported Health Claims for Intravenously Injected Therapy Products
Following a public comment period, the Federal Trade Commission has approved a final order settling charges against a Texas-based marketer and seller of intravenously injected therapy products (iV Cocktails) who allegedly made a range of deceptive and unsupported health claims about their ability to treat serious diseases such as cancer, multiple sclerosis, and congestive heart […]
FTC Requires Fresenius Medical Care AG & KGaA and NxStage Medical, Inc. to Divest Bloodline Tubing Assets to B. Braun Medical, Inc. as a Condition of Merger
The Federal Trade Commission will require healthcare companies Fresenius Medical Care AG & KGaA (Fresenius) and NxStage Medical, Inc. (NxStage) to divest all rights and assets related to NxStage’s bloodline tubing set business to B. Braun Medical, Inc. (B. Braun) as part of a settlement resolving charges that Fresenius’s proposed $2 billion acquisition of NxStage […]
FTC Enters Global Settlement to Resolve Reverse-Payment Charges against Teva
The Federal Trade Commission has reached a global settlement resolving pending claims in three separate federal court antitrust lawsuits involving subsidiaries of pharmaceutical manufacturer Teva Pharmaceuticals Industries Ltd. If approved by the various courts, the stipulated order will prohibit Teva from engaging in reverse-payment patent settlement agreements that impede consumer access to lower-priced generic drugs. […]